ロイコトリエン修飾剤の世界市場レポート 2025年

ロイコトリエン修飾剤市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.2％で302億米ドルに成長します。この予測期間の成長は、医療インフラの増加や可処分所得の増加による新興国市場での大きな成長機会、個別化医療へのシフト、遠隔医療や遠隔患者モニタリングの採用の増加、新薬候補や製剤に焦点を当てた研究開発の継続、規制の枠組みの変化の予測などに起因しています。予測期間における主な動向としては、モバイルアプリやウェアラブルデバイスなどのデジタルヘルス技術の統合、人工知能（AI）や機械学習アルゴリズムの統合、新規治療ターゲットの探索、患者参加型ソリューションやツールの開発、医薬品製造の効率性と柔軟性を高めるための連続製造プロセスの採用などが挙げられます。

喘息とアレルギー性疾患の有病率の増加は、ロイコトリエン修飾薬市場の今後の成長を促進する見通しです。喘息とアレルギー疾患は、さまざまなアレルゲンによって引き起こされる免疫系の過敏性障害の範囲を包含し、炎症と関連症状を引き起こします。喘息およびアレルギー疾患の増加は、汚染物質への曝露の増加、気候パターンの変化、気温の上昇、人口密度の増加などの要因に起因しています。ロイコトリエン修飾剤は、喘息やアレルギーの症状を管理・緩和する上で重要な役割を果たします。また、呼吸機能を改善し、炎症を抑え、慢性的な呼吸器系の問題を抱える人々にとって、より安全で効果的な治療法を提供します。例えば、全米保健統計センター（NCHS）が2024年5月に発表したデータによると、米国の18歳以上の成人における現在の喘息有病率は、2021年の8.4％から2022年には8.7％へと増加しています。さらに、同じ年齢層の成人の過去12ヵ月以内の喘息エピソードの発生率は、2021年の3.3％から2022年には3.7％に上昇しました。したがって、喘息やアレルギー疾患の発生率の上昇は、ロイコトリエン修飾薬市場の主要な促進要因です。

ロイコトリエン調節薬市場の主要企業は、製品ラインナップを拡充し、より便利で効率的な治療に対する需要の高まりに対応するため、徐放性（ER）錠剤を含むジェネリック製剤の開発に注力しています。ジェネリックの徐放性（ER）錠剤は、有効成分を長期間にわたって徐々に放出するように設計されており、即時放出型製剤に比べて投与スケジュールや利便性が改善されています。例えば、Camber Pharmaceuticals Inc.は2023年4月にZileuton ER錠をポートフォリオに加えました。この錠剤は、成人および12歳以上の小児における喘息の予防と慢性治療に適応があります。急性喘息発作の回復を目的としていないが、そのような喘息増悪時に継続投与が可能です。ジレイトンER錠は、強さ600mgの120錠入りです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ロイコトリエン修飾剤PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のロイコトリエン修飾剤市場：成長率分析
• 世界のロイコトリエン修飾剤市場の実績：規模と成長, 2019-2024
• 世界のロイコトリエン修飾剤市場の予測：規模と成長, 2024-2029, 2034F
• 世界ロイコトリエン修飾剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のロイコトリエン修飾剤市場薬剤の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• モンテルカスト
• ザフィルルカスト
• ジレウトンER
• ジレウトン
• 世界のロイコトリエン修飾剤市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タブレット
• チュアブル錠
• 経口顆粒
• 世界のロイコトリエン修飾剤市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• 小売薬局
• ドラッグストア
• オンライン薬局
• 世界のロイコトリエン修飾剤市場モンテルカストの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤の処方
• チュアブル錠製剤
• 経口顆粒
• 世界のロイコトリエン修飾剤市場ザフィルルカストの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤の処方
• 世界のロイコトリエン修飾剤市場、Zileuton ERのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 徐放性錠剤製剤
• 世界のロイコトリエン修飾剤市場、Zileutonのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 錠剤の処方
• 経口懸濁液製剤

第7章 地域別・国別分析

• 世界のロイコトリエン修飾剤市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のロイコトリエン修飾剤市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ロイコトリエン修飾剤市場：競合情勢
• ロイコトリエン修飾剤市場：企業プロファイル
  • Merck And Co. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Teva Pharmaceutical Industries Ltd.
• Hetero Drugs Limited
• Sun Pharmaceutical Industries
• Sumitomo Dainippon Pharma
• Chiesi Farmaceutici S.p.A.
• Cipla Limited
• Aurobindo Pharma Limited
• Dr. Reddy's Laboratories
• Apotex Pharmaceutical Holdings Inc.
• Torrent Pharmaceuticals Ltd.
• DAVA Pharmaceuticals
• Alembic Pharmaceuticals Ltd.
• Starallergens Greer Ltd

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ロイコトリエン修飾剤市場2029：新たな機会を提供する国
• ロイコトリエン修飾剤市場2029：新たな機会を提供するセグメント
• ロイコトリエン修飾剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Leukotriene modifiers are a class of medications used to manage and treat allergic rhinitis (hay fever) and asthma by blocking the action or production of leukotrienes in the body. Leukotrienes are chemicals that contribute to inflammation, bronchoconstriction (narrowing of the airways), and mucus production associated with these conditions. By inhibiting leukotrienes, these medications help reduce symptoms such as wheezing, shortness of breath, and nasal congestion.

The main types of leukotriene modifiers include montelukast, zafirlukast, zileuton er, and zileuton. Montelukast, for instance, is a leukotriene receptor antagonist used to prevent and manage asthma and relieve symptoms of seasonal allergies. These medications are available in various forms such as tablets, chewable tablets, and oral granules, and are distributed through channels such as hospital pharmacies, retail pharmacies, drug stores, and online pharmacies.

The leukotriene modifiers market research report is one of a series of new reports from the business research company that provides leukotriene modifiers market statistics, including leukotriene modifiers industry global market size, regional shares, competitors with an leukotriene modifiers market share, detailed leukotriene modifiers market segments, market trends and opportunities, and any further data you may need to thrive in the leukotriene modifiers industry. This leukotriene modifiers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The leukotriene modifiers market size has grown strongly in recent years. It will grow from $22.33 billion in 2024 to $23.77 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to the growing impact of regulatory approvals, rising awareness among healthcare professionals and patients about the benefits of leukotriene modifiers, expiration of patents for certain leukotriene modifier drugs allowed for the entry of generic versions, expansion of indications for leukotriene modifiers, growing collaborations between pharmaceutical companies and healthcare organizations.

The leukotriene modifiers market size is expected to see strong growth in the next few years. It will grow to $30.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to significant growth opportunities in emerging markets due to increasing healthcare infrastructure and rising disposable incomes shift towards personalized medicine, increasing adoption of telemedicine and remote patient monitoring, ongoing research and development efforts focused on novel drug candidates and formulations, and anticipated changes in regulatory frameworks. Major trends in the forecast period include the integration of digital health technologies such as mobile apps and wearable devices, integration of artificial intelligence (AI) and machine learning algorithms, exploration of novel therapeutic targets, development of patient engagement solutions and tools, and adoption of continuous manufacturing processes for increased efficiency and flexibility in drug production.

The increasing prevalence of asthma and allergic conditions is poised to drive the growth of the leukotriene modifier market in the future. Asthma and allergic conditions encompass a range of immune system hypersensitivity disorders triggered by various allergens, leading to inflammation and related symptoms. The rise in asthma and allergic conditions can be attributed to factors such as heightened exposure to pollutants, changing climate patterns, rising temperatures, and increased population density. Leukotriene modifiers play a crucial role in managing and alleviating symptoms associated with asthma and allergic conditions. They also improve respiratory function, reduce inflammation, and offer a safer and more effective treatment option for individuals with chronic respiratory issues. For example, data published by the National Center for Health Statistics (NCHS) in May 2024 indicated an increase in the prevalence of current asthma among adults aged 18 and over in the United States, from 8.4% in 2021 to 8.7% in 2022. Additionally, the incidence of asthma episodes within the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, the rising incidence of asthma and allergic conditions is a key driver for the leukotriene modifier market.

Major companies in the leukotriene modifier market are concentrating on developing generic formulations, including extended-release (ER) tablets, to broaden their product offerings and meet the growing demand for more convenient and efficient treatments. Generic extended-release (ER) tablets are designed to gradually release active ingredients over an extended period, offering improved dosing schedules and convenience compared to immediate-release formulations. For instance, Camber Pharmaceuticals Inc. added Zileuton ER Tablets to its portfolio in April 2023. These tablets are indicated for asthma prophylaxis and chronic treatment in adults and children aged 12 years and older. They are not meant for acute asthma attack reversal but can be continued during such exacerbations. Zileuton ER Tablets are available in 600 mg strength in 120-count bottles.

In April 2023, SK Capital Partners LP acquired Apotex Pharmaceutical Holdings Inc. to leverage its renowned brand, diverse product portfolio, global presence, and skilled team for growth and shareholder value enhancement. Apotex Pharmaceutical Holdings Inc., based in Canada, manufactures leukotriene modifiers such as Montelukast drugs.

Major companies operating in the leukotriene modifiers market are Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.

North America was the largest region in the leukotriene modifiers market in 2024. The regions covered in the leukotriene modifiers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the leukotriene modifiers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The leukotriene modifiers market consists of sales of modafinil, armodafinil, amphetamine-based stimulants, fluoxetine, and sertraline. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Leukotriene Modifiers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on leukotriene modifiers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for leukotriene modifiers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The leukotriene modifiers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Type: Montelukast; Zafirlukast; Zileuton ER; Zileuton
• 2) By Form: Tablets; Chewable Tablets; Oral Granules
• 3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies
• Subsegments:
• 1) By Montelukast: Tablet Formulation; Chewable Tablet Formulation; Oral Granules
• 2) By Zafirlukast: Tablet Formulation
• 3) By Zileuton ER: Extended-Release Tablet Formulation
• 4) By Zileuton: Tablet Formulation; Oral Suspension Formulation
• Companies Mentioned: Merck And Co.; Sanofi SA; AstraZeneca PLC; Novartis AG; GlaxoSmithKline plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Leukotriene Modifiers Market Characteristics

3. Leukotriene Modifiers Market Trends And Strategies

4. Leukotriene Modifiers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Leukotriene Modifiers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Leukotriene Modifiers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Leukotriene Modifiers Market Growth Rate Analysis
• 5.4. Global Leukotriene Modifiers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Leukotriene Modifiers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Leukotriene Modifiers Total Addressable Market (TAM)

6. Leukotriene Modifiers Market Segmentation

• 6.1. Global Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Montelukast
• Zafirlukast
• Zileuton ER
• Zileuton
• 6.2. Global Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Chewable Tablets
• Oral Granules
• 6.3. Global Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• 6.4. Global Leukotriene Modifiers Market, Sub-Segmentation Of Montelukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• Chewable Tablet Formulation
• Oral Granules
• 6.5. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zafirlukast, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• 6.6. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton ER, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extended-Release Tablet Formulation
• 6.7. Global Leukotriene Modifiers Market, Sub-Segmentation Of Zileuton, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet Formulation
• Oral Suspension Formulation

7. Leukotriene Modifiers Market Regional And Country Analysis

• 7.1. Global Leukotriene Modifiers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Leukotriene Modifiers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Leukotriene Modifiers Market

• 8.1. Asia-Pacific Leukotriene Modifiers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Leukotriene Modifiers Market

• 9.1. China Leukotriene Modifiers Market Overview
• 9.2. China Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Leukotriene Modifiers Market

• 10.1. India Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Leukotriene Modifiers Market

• 11.1. Japan Leukotriene Modifiers Market Overview
• 11.2. Japan Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Leukotriene Modifiers Market

• 12.1. Australia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Leukotriene Modifiers Market

• 13.1. Indonesia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Leukotriene Modifiers Market

• 14.1. South Korea Leukotriene Modifiers Market Overview
• 14.2. South Korea Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Leukotriene Modifiers Market

• 15.1. Western Europe Leukotriene Modifiers Market Overview
• 15.2. Western Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Leukotriene Modifiers Market

• 16.1. UK Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Leukotriene Modifiers Market

• 17.1. Germany Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Leukotriene Modifiers Market

• 18.1. France Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Leukotriene Modifiers Market

• 19.1. Italy Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Leukotriene Modifiers Market

• 20.1. Spain Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Leukotriene Modifiers Market

• 21.1. Eastern Europe Leukotriene Modifiers Market Overview
• 21.2. Eastern Europe Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Leukotriene Modifiers Market

• 22.1. Russia Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Leukotriene Modifiers Market

• 23.1. North America Leukotriene Modifiers Market Overview
• 23.2. North America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Leukotriene Modifiers Market

• 24.1. USA Leukotriene Modifiers Market Overview
• 24.2. USA Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Leukotriene Modifiers Market

• 25.1. Canada Leukotriene Modifiers Market Overview
• 25.2. Canada Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Leukotriene Modifiers Market

• 26.1. South America Leukotriene Modifiers Market Overview
• 26.2. South America Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Leukotriene Modifiers Market

• 27.1. Brazil Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Leukotriene Modifiers Market

• 28.1. Middle East Leukotriene Modifiers Market Overview
• 28.2. Middle East Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Leukotriene Modifiers Market

• 29.1. Africa Leukotriene Modifiers Market Overview
• 29.2. Africa Leukotriene Modifiers Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Leukotriene Modifiers Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Leukotriene Modifiers Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Leukotriene Modifiers Market Competitive Landscape And Company Profiles

• 30.1. Leukotriene Modifiers Market Competitive Landscape
• 30.2. Leukotriene Modifiers Market Company Profiles
  • 30.2.1. Merck And Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Leukotriene Modifiers Market Other Major And Innovative Companies

• 31.1. Boehringer Ingelheim International GmbH
• 31.2. Viatris Inc.
• 31.3. Teva Pharmaceutical Industries Ltd.
• 31.4. Hetero Drugs Limited
• 31.5. Sun Pharmaceutical Industries
• 31.6. Sumitomo Dainippon Pharma
• 31.7. Chiesi Farmaceutici S.p.A.
• 31.8. Cipla Limited
• 31.9. Aurobindo Pharma Limited
• 31.10. Dr. Reddy's Laboratories
• 31.11. Apotex Pharmaceutical Holdings Inc.
• 31.12. Torrent Pharmaceuticals Ltd.
• 31.13. DAVA Pharmaceuticals
• 31.14. Alembic Pharmaceuticals Ltd.
• 31.15. Starallergens Greer Ltd

32. Global Leukotriene Modifiers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Leukotriene Modifiers Market

34. Recent Developments In The Leukotriene Modifiers Market

35. Leukotriene Modifiers Market High Potential Countries, Segments and Strategies

• 35.1 Leukotriene Modifiers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Leukotriene Modifiers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Leukotriene Modifiers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer